- Home
- HALO vs LW Comparison
HALO vs LW Comparison
Compare HALO & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- LW
- Stock Information
- Founded
- HALO 1998
- LW 1950
- Country
- HALO United States
- LW United States
- Employees
- HALO N/A
- LW N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- LW Packaged Foods
- Sector
- HALO Health Care
- LW Consumer Staples
- Exchange
- HALO Nasdaq
- LW Nasdaq
- Market Cap
- HALO 7.4B
- LW 7.3B
- IPO Year
- HALO N/A
- LW N/A
- Fundamental
- Price
- HALO $66.71
- LW $50.92
- Analyst Decision
- HALO Buy
- LW Buy
- Analyst Count
- HALO 9
- LW 12
- Target Price
- HALO $63.78
- LW $72.17
- AVG Volume (30 Days)
- HALO 2.0M
- LW 1.6M
- Earning Date
- HALO 05-06-2025
- LW 04-03-2025
- Dividend Yield
- HALO N/A
- LW 2.91%
- EPS Growth
- HALO 55.40
- LW N/A
- EPS
- HALO 3.76
- LW 2.55
- Revenue
- HALO $1,084,306,000.00
- LW $6,387,400,000.00
- Revenue This Year
- HALO $20.06
- LW $1.32
- Revenue Next Year
- HALO $24.20
- LW $1.19
- P/E Ratio
- HALO $17.52
- LW $19.92
- Revenue Growth
- HALO 25.64
- LW N/A
- 52 Week Low
- HALO $41.28
- LW $47.90
- 52 Week High
- HALO $70.51
- LW $89.51
- Technical
- Relative Strength Index (RSI)
- HALO 58.91
- LW 46.90
- Support Level
- HALO $65.68
- LW $50.23
- Resistance Level
- HALO $69.94
- LW $51.97
- Average True Range (ATR)
- HALO 2.58
- LW 1.18
- MACD
- HALO 0.80
- LW -0.04
- Stochastic Oscillator
- HALO 63.69
- LW 50.76
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About LW Lamb Weston Holdings Inc.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 14% of fiscal 2024 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.